AI MARKET SCANNING

$VIRP.PA

Virbac SA

European UnionEUROPEAN UNION
FREE PREVIEW
📅 Next Earnings: Sep 17, 2026 🌙 Close🌐 Website🏛️ Euronext Paris📁 Health Technology🏭 Biotechnology
AVG HISTORICAL GAP0.00%
MAX GAP RECORD0.00%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

QUANTITATIVE LIVE RADAR BLOTTER

Institutional execution stream for $VIRP.PA

EXECUTIONS3 LOGS
WIN RATE••.•%
NET ROI+•••.••%
Execution DateStrategy & SetupDirectionExecution RangeHold TimeExit TriggerNet PnL
2026-09-11QUANT ALGOSELL x5$•••.•• → $•••.••2465m🔒 ENCRYPTED+3.19%
••••-••-••🔒 LOCKED••• x•$•••.•• → $•••.••••h ••m🔒 LOCKED+••.••%
••••-••-••🔒 LOCKED••• x•$•••.•• → $•••.••••h ••m🔒 LOCKED+••.••%
🔒 Institutional Data Protected

Exact execution prices, stop-loss triggers, and full trade logs are reserved for PRO members.

UNLOCK FULL BLOTTER

VOLATILITY & BIAS PROFILE

AVG VOLATILITY0.0%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Virbac SA engages in the manufacture and sale of veterinary medicines. It operates through the following business segments: Companion Animals and Farm Animals. It develops vaccines, antibiotics, anesthetics, dermatological products, and drugs for pest control, inflammation, dental care, and ophthalmological conditions of pets and livestock. It also operates through the following geographical segments: France, Europe, Latin America, North America, Asia,… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL